https://www.taxtmi.com/caselaws?id=246695 The Tribunal ruled in favor of the appellant, a pharmaceutical manufacturer, in a dispute over the assessable value of physician's samples. The appellant argued that the value should be based on Maximum Retail Price (MRP) as per the Cadila Pharmaceuticals case. The Tribunal agreed, setting aside the Revenue's claim for actual transaction value. Consequently, the penalties imposed under Sec.11A of the Central Excise Act, 1944 were deemed unsustainable, providing relief to the appellant. The decision aligned with the Cadila Pharmaceuticals case, ensuring consistency in assessable value calculation methodology. en-us Mon, 10 Dec 2012 00:00:00 +0530 Sun, 20 Apr 2014 16:42:57 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=246695 The Tribunal ruled in favor of the appellant, a pharmaceutical manufacturer, in a dispute over the assessable value of physician's samples. The appellant argued that the value should be based on Maximum Retail Price (MRP) as per the Cadila Pharmaceuticals case. The Tribunal agreed, setting aside the Revenue's claim for actual transaction value. Consequently, the penalties imposed under Sec.11A of the Central Excise Act, 1944 were deemed unsustainable, providing relief to the appellant. The decision aligned with the Cadila Pharmaceuticals case, ensuring consistency in assessable value calculation methodology. Case-Laws Central Excise Mon, 10 Dec 2012 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=246695